MedPath
HSA Approval

HALOXEN 5 TABLET 5 mg

SIN09918P

HALOXEN 5 TABLET 5 mg

HALOXEN 5 TABLET 5 mg

July 31, 1998

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05AD01

haloperidol

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

HALOPERIDOL

5 mg

Haloperidol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HALOXEN 5 TABLET 5 mg - HSA Approval | MedPath